A combination of plasma DAO and citrulline levels as a potential marker for acute mesenteric ischemia

Libyan Journal of Medicine

Volumn 8, Issue 1, 2013, Pages

  Çakmaz, Ridvan ^a   Büyükaşik, Oktay ^b   Kahramansoy, Nurettin ^c   Erkol, Hayri ^c   Çöl, Cavit ^c   Boran, Çetin ^c   Buǧdayci, Güler ^c  

^a State Hospital   (Turkey)

^b Lokman Hekim Hospital   (Turkey)

^c ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

Author keywords

Animal model; Citrulline; Diamine oxidase; Experimental; Intestines

Indexed keywords

AMINE OXIDASE (COPPER CONTAINING); CITRULLINE;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE MARKER; DISEASE SEVERITY; EARLY DIAGNOSIS; ENZYME BLOOD LEVEL; FEMALE; HISTOPATHOLOGY; INTESTINE ISCHEMIA; MESENTERIC ISCHEMIA; NONHUMAN; RAT;

EID: 84875682499     PISSN: 19932820     EISSN: 18196357     Source Type: Journal    
DOI: 10.3402/ljm.v8i0.20596     Document Type: Article

References (44)

1. Alhan E, Usta A, Cekiç A, Saglam K, TürkyIlmaz S, Cinel A. A study on 107 patients with acute mesenteric ischemia over 30 years. Int J Surg. 2012; 10: 510-3.
2. Gupta PK, Natarajan B, Gupta H, Fang X, Fitzgibbons RJ Jr. Morbidity and mortality after bowel resection for acute mesenteric ischemia. Surgery. 2011; 150: 779-87.
3. Acosta-Merida MA, Marchena-Gomez J, Hemmersbach-Miller M, Roque-Castellano C, Hernandez-Romero JM. Identification of risk factors for perioperative mortality in acute mesenteric ischemia. World J Surg. 2006; 30: 1579-85.
4. Acosta S. Epidemiology of mesenteric vascular disease: clinical implications. Semin Vasc Surg. 2010; 23: 4-8.
5. Newton WB 3rd, Sagransky MJ, Andrews JS, Hansen KJ, Corriere MA, Goodney PP, et al. Outcomes of revascularized acute mesenteric ischemia in the American College of Surgeons National Surgical Quality Improvement Program database. Am Surg. 2011; 77: 832-8.
6. Demir IE, Ceyhan GO, Friess H. Beyond lactate: is there a role for serum lactate measurement in diagnosing acute mesenteric ischemia? Dig Surg. 2012; 29: 226-35.
7. Acosta S, Block T, Björnsson S, Resch T, Björck M, Nilsson T. Diagnostic pitfalls at admission in patients with acute superior mesenteric artery occlusion. J Emerg Med. 2012; 42: 635-41.
8. Acosta S, Nilsson T. Current status on plasma biomarkers for acute mesenteric ischemia. J Thromb Thrombolysis. 2012; 33: 355-61.
9. Karabulut K, Gül M, Dündar ZD, Cander B, Kurban S, Toy H. Diagnostic and prognostic value of procalcitonin and phosphorus in acute mesenteric ischemia. Ulus Travma Acil Cerrahi Derg. 2011; 17: 193-8.
10. Akyildiz H, Akcan A, Oztürk A, Sozuer E, Kucuk C, Karahan I. The correlation of the D-dimer test and biphasic computed tomography with mesenteric computed tomography angiography in the diagnosis of acute mesenteric ischemia. Am J Surg. 2009; 197: 429-33.
11. D'Agostino L, D'Argenio G, Ciacci C, Daniele B, Macchia V, Mazzacca G. Diamine oxidase in rat small bowel: distribution in different segments and cellular location. Enzyme. 1984; 31: 217-20.
12. Luk GD, Bayless TM, Baylin SB. Diamine oxidase (histaminase). A circulating marker for rat intestinal mucosal maturation and integrity. J Clin Invest. 1980; 66: 66-70.
13. Wolvekamp MC, de Bruin RW. Diamine oxidase: an overview of historical, biochemical and functional aspects. Dig Dis. 1994; 12: 2-14.
14. Bragg LE, Thompson JS, West WW. Intestinal diamine oxidase levels reflect ischemic injury. J Surg Res. 1991; 50: 228-33.
15. Fujiskai J, Fujimoto K, Oohara A, Sakata T, Hirano M, Ohyama T, et al. Roles of histamine and diamine oxidase in mucosa of rat small intestine after ischemia reperfusion. Dig Dis Sci. 1993; 38: 1195-200.
16. Cai C, Li W, Chen J, Li X, Chen S. Diamine oxidase as a marker for diagnosis of superior mesenteric arterial occlusion. Hepatogastroenterology. 2012; 59: 155-8.
17. Curis E, Nicolis I, Moinard C, Osowska S, Zerrouk N, Benazeth S, et al. Almost all about citrulline in mammals. Amino Acids. 2005; 29: 177-205.
18. Crenn P, Messing B, Cynober L. Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction. Clin Nutr. 2008; 27: 328-39.
19. Elkhatib I, Buchman AL. Plasma citrulline concentration as a marker for disease activity in patients with Crohn's disease. J Clin Gastroenterol. 2012; 46: 308-10.
20. Herbers AH, Feuth T, Donnelly JP, Blijlevens NM. Citrullinebased assessment score: first choice for measuring and monitoring intestinal failure after high-dose chemotherapy. Ann Oncol. 2010; 21: 1706-11.
21. Tizianello A, De Ferrari G, Garibotto G, Gurreri G, Robaudo C. Renal metabolism of amino acids and ammonia in subjects with normal renal function and in patients with chronic renal insufficiency. J Clin Invest. 1980; 65: 1162-73.
22. Ozkan KU, Ozokutan BH, Inanç F, Boran C, Kilinç M. Does maternal nicotine exposure during gestation increase the injury severity of small intestine in the newborn rats subjected to experimental necrotizing enterocolitis? J Pediatr Surg. 2005; 40: 484-8.
23. Maretta M, Tóth Š, Bujdoš M, Tóth Š Jr, Jonecová Z, Veselá J. Alterations of epithelial layer after ischemic preconditioning of small intestine in rats. J Mol Histol. 2012; 43: 171-8.
24. Chang M, Kistler EB, Schmid-Schönbein GW. Disruption of the mucosal barrier during gut ischemia allows entry of digestive enzymes into the intestinal wall. Shock. 2012; 37: 297-305.
25. Boros M, Takaichi S, Hatanaka K. Ischemic time-dependent microvascular changes and reperfusion injury in the rat small intestine. J Surg Res. 1995; 59: 311-20.
26. Tunc T, Uysal B, Atabek C, Kesik V, Caliskan B, Oztas E, et al. Erdosteine and ebselen as useful agents in intestinal ischemia/ reperfusion injury. J Surg Res. 2009; 155: 210-6.
27. Unalp HR, Atahan K, Kamer E, Yaşa H, Tarcan E, Onal MA. Prognostic factors for hospital mortality in patients with acute mesenteric ischemia who undergo intestinal resection due to necrosis. Ulus Travma Acil Cerrahi Derg. 2010; 16: 63-70.
28. Zhang FX, Ma BB, Liang GZ, Zhang H. Analysis of serum enzyme levels in a rabbit model of acute mesenteric ischemia. Mol Med Report. 2011; 4: 1095-9.
29. Wollin A, Navert H, Bounous G. Effect of intestinal ischemia on diamine oxidase activity in rat intestinal tissue and blood. Gastroenterology. 1981; 80: 349-55.
30. Zhang XY, Liu ZM, Wen SH, Li YS, Li Y, Yao X, et al. Dexmedetomidine administration before, but not after, ischemia attenuates intestinal injury induced by intestinal ischemiareperfusion in rats. Anesthesiology. 2012; 116: 1035-46.
31. Nakagawa H, Tsunooka N, Yamamoto Y, Yoshida M, Nakata T, Kawachi K. Intestinal ischemia/reperfusion-induced bacterial translocation and lung injury in atherosclerotic rats with hypoadiponectinemia. Surgery. 2009; 145: 48-56.
32. Wen SH, Li Y, Li C, Xia ZQ, Liu WF, Zhang XY, et al. Ischemic postconditioning during reperfusion attenuates intestinal injury and mucosal cell apoptosis by inhibiting JAK/STAT signaling activation. Shock. 2012; 38: 411-9.
33. Tsunooka N, Maeyama K, Hamada Y, Imagawa H, Takano S, Watanabe Y, et al. Bacterial translocation secondary to small intestinal mucosal ischemia during cardiopulmonary bypass. Measurement by diamine oxidase and peptidoglycan. Eur J Cardiothorac Surg. 2004; 25: 275-80.
34. Fitzgibbons S, Ching YA, Valim C, Zhou J, Iglesias J, Duggan C, et al. Relationship between serum citrulline levels and progression to parenteral nutrition independence in children with short bowel syndrome. J Pediatr Surg. 2009; 44: 928-32.
35. Jianfeng G, Weiming Z, Ning L, Fangnan L, Li T, Nan L, et al. Serum citrulline is a simple quantitative marker for small intestinal enterocytes mass and absorption function in short bowel patients. J Surg Res. 2005; 127: 177-82.
36. Hibi T, Nishida S, Garcia J, Tryphonopoulos P, Tekin A, Selvaggi G, et al. Citrulline level is a potent indicator of acute rejection in the long term following pediatric intestinal/ multivisceral transplantation. Am J Transplant. 2012; 12 (Suppl 4): S27-32.
37. Gondolesi G, Fishbein T, Chehade M, Tschernia A, Magid M, Kaufman S, et al. Serum citrulline is a potential marker for rejection of intestinal allografts. Transplant Proc. 2002; 34: 918-20.
38. Wedlake L, McGough C, Hackett C, Thomas K, Blake P, Harrington K, et al. Can biological markers act as non-invasive, sensitive indicators of radiation-induced effects in the gastrointestinal mucosa? Aliment Pharmacol Ther. 2008; 27: 980-7.
39. Onal C, Kotek A, Unal B, Arslan G, Yavuz A, Topkan E, et al. Plasma citrulline levels predict intestinal toxicity in patients treated with pelvic radiotherapy. Acta Oncol. 2011; 50: 1167-74.
40. Pan L, Wang X, Li W, Li N, Li J. The intestinal fatty acid binding protein diagnosing gut dysfunction in acute pancreatitis: a pilot study. Pancreas. 2010; 39: 633-8.
41. Lundy J, Chung KK, Cancio LC, White CE, Ziegler TR. Observations on serial plasma citrulline concentrations in a patient with intestinal ischemia and full-thickness necrosis after severe thermal injury. J Burn Care Res. 2012; 33: e316-8.
42. Piton G, Manzon C, Cypriani B, Carbonnel F, Capellier G. Acute intestinal failure in critically ill patients: is plasma citrulline the right marker? Intensive Care Med. 2011; 37: 911-7.
43. Noordally SO, Sohawon S, Semlali H, Michely D, Devriendt J, Gottignies P. Is there a correlation between circulating levels of citrulline and intestinal dysfunction in the critically ill? Nutr Clin Pract. 2012; 27: 527-32.
44. Yi L, Lingshan G, Cui Y, Xiaoxing Y, Junnian Z. A preliminary study on protective effect of L-citrulline against ischemiareperfusion induced gastric mucosal lesions in rat. Indian J Pharmacol. 2012; 44: 31-5.